Imagen de Portada

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Model‐Robust Standardization in Cluster‐Randomized Trials
por: Fan Li, et al.
Publicado: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
por: Yunyi Liu, et al.
Publicado: (2026)

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
por: Xi Fang, et al.
Publicado: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
por: Hao Wang, et al.
Publicado: (2026)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
por: Yuwei Cheng, et al.
Publicado: (2026)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
por: Elizabeth L. Turner, et al.
Publicado: (2026)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
por: Analissa Avila, et al.
Publicado: (2025)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
por: Zhe Chen, et al.
Publicado: (2026)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
por: Alessandro Gasparini, et al.
Publicado: (2025)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
por: Kendra Davis‐Plourde, et al.
Publicado: (2025)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
por: Peter C. Austin
Publicado: (2026)

Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
por: Jules Antoine Pereira Macedo, et al.
Publicado: (2025)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
por: Jingyan Fu, et al.
Publicado: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
por: Liwen Wu, et al.
Publicado: (2025)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
por: Jingya Gao, et al.
Publicado: (2024)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
por: Maria Vittoria Chiaruttini, et al.
Publicado: (2026)

Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
por: Wenli Liu, et al.
Publicado: (2025)

A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters
por: Haidy A. Newer
Publicado: (2026)

Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials
por: Kota Sawada, et al.
Publicado: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
por: Xiaotian Chen, et al.
Publicado: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
por: Antonio D'Alessandro, et al.
Publicado: (2026)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
por: Daniel E. Schwartz, et al.
Publicado: (2026)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
por: Ruoyuan Qian, et al.
Publicado: (2025)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
por: Yeonhee Park, et al.
Publicado: (2025)

A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
por: Niki Z. Petrakos, et al.
Publicado: (2025)

Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome
por: Xinxin Sun, et al.
Publicado: (2024)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
por: Marianthie Wank, et al.
Publicado: (2024)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
por: Godwin Yung, et al.
Publicado: (2025)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
por: Amitay Kamber, et al.
Publicado: (2025)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
por: Hyejung Jung, et al.
Publicado: (2026)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
por: Florian Klinglmüller, et al.
Publicado: (2025)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
por: Tianyu Zhan, et al.
Publicado: (2026)

Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
por: Jiaqi Tong, et al.
Publicado: (2025)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
por: Melody A. Owen, et al.
Publicado: (2025)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
por: Ethan Ashby, et al.
Publicado: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
por: Adrien Ollier, et al.
Publicado: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
por: Fei Gao, et al.
Publicado: (2025)

Futility Monitoring in Clinical Trials
por: Ana M. Ortega‐Villa, et al.
Publicado: (2025)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
por: Guangyong Zou, et al.
Publicado: (2024)

Robust Distribution‐Free Tests for the Linear Model
por: Torey Hilbert, et al.
Publicado: (2026)